Bayesian Capital Management’s Arvinas ARVN Stock Holding History

Bayesian Capital Management’s Portfolio ARVN Stock Details ARVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-19,550	Closed	-$520K	–	668
2024 Q2	$520K	Buy	+19,550	New	+$623K	0.06%	359

Other funds holding ARVN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bayesian Capital Management's ARVN Position: Q3 2024 in Review

Bayesian Capital Management sold out of Arvinas (ARVN) in Q3 2024, closing a stake of 19,550 shares — an estimated $520K sold.

Bayesian Capital Management first reported a position in ARVN in Q2 2024 and held it in 1 quarter. The position peaked at $520K in Q2 2024. 206 funds tracked by Wall St. Rank hold ARVN as of Q3 2024.

Bayesian Capital Management reported no remaining Arvinas position as of Q3 2024 after selling out during the quarter.
Bayesian Capital Management sold 19,550 Arvinas shares in Q3 2024, an estimated $520K.
Bayesian Capital Management first reported a position in Arvinas in Q2 2024 and held it in 1 quarter.
Bayesian Capital Management's Arvinas position peaked at $520K in Q2 2024.
206 funds tracked by Wall St. Rank held Arvinas as of Q3 2024.

Based on Bayesian Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.